$QXO

QXO, Inc. (QXO): Completion of Acquisition or Disposition of Assets

QXO, Inc. (QXO) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 5 tm2618991d7_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version INCREMENTAL ASSUMPTION AND AMENDMENT AGREEMENT NO. 2 Dated as of July 1, 2026 among QUEEN HOLDCO, LLC, as Holdings, QXO BUILDING PRODUCTS, INC., as Borrower, THE SUBSIDIARY LOAN PARTIES PARTY HERETO, THE

Original reporting
Published Jul 1, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$QXO
Neutral
medium confidence
Mentioned
$QXO
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$QXONeutralMed
01

Why it matters

The incremental Term B financing ($3.0B) is intended to fund part of the Titanium acquisition and related fees, which can increase leverage and influence credit risk perception while also confirming deal execution progress.

02

Market read

Deal completion plus $3.0B incremental Term B financing is a concrete capital-structure and execution catalyst for QXO, relevant for both equity and credit traders.

03

What to watch

Traders will want the missing details: incremental loan pricing/margins, maturity/amortization, any covenant headroom changes, and whether the asset disposition affects working capital or collateral.

Relevance 7/10Novelty 6/10Timing: immediately after-hours / filed July 1, 2026 (8-K completion and financing terms)

Background

The SEC 8-K references Item 2.01 completion of an acquisition/disposition and Item 1.01 entry into a material definitive agreement, with an exhibit describing an Incremental Assumption and Amendment Agreement No. 2 for $3.0B of 2026 Incremental Term B Loans to finance the Titanium acquisition.

Company-level read

Ticker impact

$QXONeutralMedium confidence
Context

QXO’s 8-K says it completed an asset acquisition/disposition and entered a material definitive agreement tied to incremental term loan financing for the Titanium acquisition.

Expected impact

Likely modest, two-sided reaction: deal-completion support offset by higher leverage/financing risk.

Evidence & confidence

The filing discloses a $3.0B incremental Term B loan request/commitment and references financing for the Titanium acquisition; however, the excerpt lacks deal economics, pricing, and any explicit credit covenant changes beyond the amendment framework.

Market effects

Signals continued M&A leverage use in building products/contractor supply chains; may affect credit spreads for similarly levered acquirers.

No clear regional-specific impact disclosed in the excerpt.

No direct global macro linkage disclosed; financing syndicate includes major global banks but no cross-border operational change is described.

Counterpoint

Equity may not re-rate much if the incremental debt is already priced into expectations; the key driver could be the acquisition’s integration timeline rather than the financing mechanics.

Key entities

  • QXO, Inc.

    Registrant filing the 8-K; subject of the acquisition/disposition completion and incremental debt financing agreement.

  • TopBuild Corp. (Titanium)

    Target referenced in the Titanium Merger Agreement; acquisition financed in part by the incremental Term B loans.

  • Goldman Sachs Bank USA

    Named as Administrative Agent in the incremental term loan agreement exhibit.

Related articles

$QXOMed

QXO shares rise after TopBuild merger election results released (QXO)

QXO shares rose about 8% after QXO said preliminary TopBuild (BLD) merger election results were released. About 91% of TopBuild shares elected cash consideration. Under proration, each TopBuild share will receive ~$249.71 cash plus 10.211 QXO shares (final agent calculations). Election ended June 29; closing expected around July 1, 2026.

$METAMed

Jim Cramer's top 10 things to watch in the stock market Wednesday

Jim Cramer’s Wednesday watchlist cites lower stock futures and profit-taking. He highlights Meta’s reported plan to build a cloud business for AI compute, Micron’s expectation of more long-term supply deals, and Nike’s uninspiring quarter. He also notes upgrades for Salesforce/ServiceNow, a Goldman buy on FedEx Freight (PT $186), Citi raising Affirm PT to $115, QXO’s TopBuild acquisition, and U.S. export easing for Anthropic’s Claude models.

$QXOMedAI 9/10

QXO Inc. (QXO) Launches Cash Tender Offers for TopBuild (BLD) Senior Notes Amid Pending Acquisition

QXO Inc. said it launched cash tender offers and consent solicitations to buy TopBuild Corp.’s outstanding 4.125% notes due 2032 and 5.625% notes due 2034 as part of its pending acquisition of TopBuild. QXO offered $961.25 per $1,000 principal, plus $50 for early tenders ($1,011.25 total), and sought indenture amendments to remove a change-of-control offer and most restrictive covenants.

$QXOMedAI 8/10

Swedbank AB Makes New $9.66 Million Investment in QXO, Inc. $QXO

Swedbank AB bought 501,000 shares of QXO, Inc. (NYSE:QXO) in Q4 for about $9.66 million, according to HoldingsChannel.com. Other investors also increased stakes, including Vanguard and Finepoint. Analysts cited include KeyCorp raising its target to $32. QXO last reported EPS of -$0.12 on $1.73 billion revenue (meeting revenue estimates).

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.